Eli Lilly to Acquire Centessa Therapeutics for $7.8 Billion
Eli Lilly is set to acquire Centessa Therapeutics for $7.8 billion, bolstering its drug development pipeline. The acquisition provides Eli Lilly with access to Centessa's portfolio of promising drug candidates.